Skip to main content

Table 6 Predicting population coverage of MHC II epitopes

From: In silico vaccine design and epitope mapping of New Delhi metallo-beta-lactamase (NDM): an immunoinformatics approach

Population/area

Coverage (%)

Central Africa

99.86

Central America

99.90

East Africa

99.96

East Asia

98.84

Europe

100.00

North Africa

99.79

North America

100.00

Northeast Asia

99.78

Oceania

99.92

South Africa

47.29

South America

99.91

South Asia

99.94

Southeast Asia

98.68

Southwest Asia

99.55

West Africa

99.88

West Indies

98.68

World

99.91